Results for tag: "Vincristine Sulfate"

Vincristine Sulfate is a chemotherapy drug used to treat a variety of hematological malignancies, including acute lymphoblastic leukemia, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. It is a vinca alkaloid derived from the Madagascar periwinkle plant and is administered intravenously or intramuscularly. Vincristine Sulfate works by inhibiting the growth of cancer cells by interfering with the formation of microtubules, which are essential for cell division. The Vincristine Sulfate market is a subset of the larger Hematological Drugs market, which includes drugs used to treat blood-related diseases such as anemia, hemophilia, and sickle cell anemia. The market is highly competitive, with a number of large pharmaceutical companies offering Vincristine Sulfate products. Some of the companies in the Vincristine Sulfate market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and Sanofi. Show Less Read more